BeOne Medicines Ltd. (ONC)
376.88
+4.90
(+1.32%)
USD |
NASDAQ |
Aug 25, 16:00
376.88
0.00 (0.00%)
After-Hours: 19:59
BeOne Medicines Shareholders Equity (Quarterly) : 5.174B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.174B |
| March 31, 2026 | 4.761B |
| December 31, 2025 | 4.361B |
| September 30, 2025 | 4.129B |
| June 30, 2025 | 3.771B |
| March 31, 2025 | 3.500B |
| December 31, 2024 | 3.332B |
| September 30, 2024 | 3.436B |
| June 30, 2024 | 3.366B |
| March 31, 2024 | 3.360B |
| December 31, 2023 | 3.537B |
| September 30, 2023 | 3.763B |
| June 30, 2023 | 3.799B |
| March 31, 2023 | 4.157B |
| December 31, 2022 | 4.383B |
| September 30, 2022 | 4.655B |
| June 30, 2022 | 5.303B |
| March 31, 2022 | 5.885B |
| December 31, 2021 | 6.132B |
| September 30, 2021 | 3.357B |
| June 30, 2021 | 3.607B |
| March 31, 2021 | 4.004B |
| Date | Value |
|---|---|
| December 31, 2020 | 3.869B |
| September 30, 2020 | 4.287B |
| June 30, 2020 | 2.536B |
| March 31, 2020 | 2.812B |
| December 31, 2019 | 962.20M |
| September 30, 2019 | 1.278B |
| June 30, 2019 | 1.554B |
| March 31, 2019 | 1.609B |
| December 31, 2018 | 1.739B |
| September 30, 2018 | 1.970B |
| June 30, 2018 | 1.213B |
| March 31, 2018 | 1.344B |
| December 31, 2017 | 669.81M |
| September 30, 2017 | 750.14M |
| June 30, 2017 | 255.75M |
| March 31, 2017 | 308.42M |
| December 31, 2016 | 352.91M |
| September 30, 2016 | 187.83M |
| June 30, 2016 | 220.05M |
| March 31, 2016 | 243.10M |
| December 31, 2015 | 74.32M |
| September 30, 2015 | 100.08M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 1.747B |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 43.60M |
| Idorsia Ltd. | -1.480B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.176B |
| Total Liabilities (Quarterly) | 3.973B |
| Debt to Equity Ratio | 0.3961 |
| Current Ratio | 3.405 |
| Net Debt Paydown Yield | -0.71% |